Therapeutics, Inc.
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1997-01-01
- Employees
- 51
- Market Cap
- -
Clinical Trials
17
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (17 trials with phase data)• Click on a phase to view related trials
Safety, Tolerability, and Pharmacokinetics of UHE-103 Cream in Subjects With Tinea Cruris and/or Tinea Pedis
- Conditions
- Tinea CrurisTinea Pedis
- Interventions
- Drug: UHE-103 Cream
- First Posted Date
- 2022-05-05
- Last Posted Date
- 2024-04-10
- Lead Sponsor
- Therapeutics, Inc.
- Target Recruit Count
- 42
- Registration Number
- NCT05363449
- Locations
- 🇺🇸
Site #1, San Diego, California, United States
🇺🇸Site #5, Thousand Oaks, California, United States
🇺🇸Site #2, Austin, Texas, United States
A Study of the Safety and Efficacy of UHE-105 Shampoo in Subjects With Scalp Psoriasis
- First Posted Date
- 2020-01-28
- Last Posted Date
- 2020-07-09
- Lead Sponsor
- Therapeutics, Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT04243486
- Locations
- 🇺🇸
01, San Diego, California, United States
🇺🇸02, High Point, North Carolina, United States
A Safety Study of 188-0551 Spray Versus Reference Listed Drug (RLD) in Adult Subjects With Plaque Psoriasis
- Conditions
- Plaque Psoriasis
- Interventions
- Drug: 188-0551 SprayDrug: RLD
- First Posted Date
- 2019-09-06
- Last Posted Date
- 2021-05-10
- Lead Sponsor
- Therapeutics, Inc.
- Target Recruit Count
- 55
- Registration Number
- NCT04080206
- Locations
- 🇺🇸
TI Site #13, Scottsdale, Arizona, United States
🇺🇸TI Site #12, Thousand Oaks, California, United States
🇺🇸TI Site #11, Miami, Florida, United States
A Comparison Study of UHE-103 Cream in Subjects With Moccasin Type Tinea Pedis
- Conditions
- Tinea Pedis
- Interventions
- Drug: UHE-103A2B creamDrug: UHE-103A1 creamDrug: UHE-103A2 creamDrug: UHE-103B creamDrug: UHE-103A1B cream
- First Posted Date
- 2019-04-01
- Last Posted Date
- 2021-10-28
- Lead Sponsor
- Therapeutics, Inc.
- Target Recruit Count
- 240
- Registration Number
- NCT03897257
- Locations
- 🇺🇸
Site 03, San Diego, California, United States
🇺🇸Site 12, Melbourne, Florida, United States
🇺🇸Site 06, Miami, Florida, United States
A Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis
- Conditions
- Plaque Psoriasis
- Interventions
- Drug: 188-0551 SprayDrug: Vehicle Spray
- First Posted Date
- 2018-11-29
- Last Posted Date
- 2020-02-25
- Lead Sponsor
- Therapeutics, Inc.
- Target Recruit Count
- 206
- Registration Number
- NCT03759197
- Locations
- 🇺🇸
Site 06, Fort Smith, Arkansas, United States
🇺🇸Site 09, Fountain Valley, California, United States
🇺🇸Site 07, Fremont, California, United States
- Prev
- 1
- 2
- 3
- 4
- Next